Commercialization Scholar Awardee, Dr. Jianyi Zhang, is a Recipient of an $8 Million Grant to Study Bioengineered Tissue Patches

The University of Alabama at Birmingham, in collaboration with the University of Wisconsin-Madison and Duke University, has been awarded an $8 million grant from the National Heart, Lung and Blood Institute.  A recent article by Melissa Brown of  the Birmingham Business Journal highlighted the exciting and innovative research that will be conducted within these three universities.  Leading the UAB team is Dr. Jianyi Zhang, chair of the UAB Department of Biomedical Engineering and recipient of a $500,000 Commercialization Scholar award from the 2015 Alabama Innovation Fund.  Dr. Zhang leveraged this award to develop the $8 million grant proposal, securing UAB’s position as a powerhouse in the field of regenerative medicine.  Click here to read the full article from the Birmingham Business Journal and to learn more about Dr. Zhang’s work at UAB click here.